Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -912.25% is 133% below its 3-year average of -391.24%, near the low end of its 3-year range (-1064.75%–0.00%).
0.55% above its 12-month average of -917.28%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1064.75%.
NET PROFIT MARGIN
-912.25%
NET PROFIT MARGIN AVG TTM
-917.28%
NET PROFIT MARGIN AVG 3Y
-421.34%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.55%
CURRENT VS 3Y AVG
-116.51%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-260542.86%
vs the sector median at left
BioAge Labs Inc.
Market Cap
$236.82M
Net Profit Margin
-912.25%
TTM Avg
-917.28%
3Y Avg
-421.34%
5Y Avg
N/A
Market Cap
$237.57M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
Market Cap
$235.97M
Net Profit Margin
-5.14%
TTM Avg
33.66%
3Y Avg
36.64%
5Y Avg
40.60%
Market Cap
$235.66M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$235.08M
Net Profit Margin
29.04%
TTM Avg
31.61%
3Y Avg
31.96%
5Y Avg
30.60%
Market Cap
$239.01M
Net Profit Margin
-4.52%
TTM Avg
-4.68%
3Y Avg
-9.38%
5Y Avg
-10.81%
Market Cap
$239.02M
Net Profit Margin
-8.78%
TTM Avg
-964.82%
3Y Avg
-2640.79%
5Y Avg
-1760.53%
Market Cap
$232.72M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$241.34M
Net Profit Margin
-6138.26%
TTM Avg
-3731.55%
3Y Avg
-4082.97%
5Y Avg
-2721.98%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $236.82M | -912.25% | -917.28% | -421.34% | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -183.90% | -383.83% | -191.92% | -127.94% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -5.14% | 33.66% | 36.64% | 40.60% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -13.54% | -22.79% | -26.12% | -61.39% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 29.04% | 31.61% | 31.96% | 30.60% |
| High Tide Inc. (HITI)vs › | $239.01M | -4.52% | -4.68% | -9.38% | -10.81% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -8.78% | -964.82% | -2640.79% | -1760.53% |
| InflaRx N.V. (IFRX)vs › | $232.72M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -6138.26% | -3731.55% | -4082.97% | -2721.98% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 62.87% | 27.75% | 54.97% | -757.17% |
Operating Margin
-1026.3%
Net Profit Margin
-912.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1064.75% |
| 2026-03-31 | -802.78% |
| 2025-12-31 | -842.85% |
| 2025-09-30 | -982.04% |
| 2025-06-30 | -893.99% |
| 2025-03-31 | -890.97% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
